Start Logo
  • About

    About START

    Welcome to the START Center for Cancer Research. We are a global leader in cancer research, dedicated to the relentless pursuit of hope for patients and their families.

    Cure Starts here

    About

    • Company
    • Hope Hub
    • Leadership
    • Principal Investigators
    • Careers
    • Contact

    Our Services

    • Preclinical
    • Early Phase

  • Who We Serve

    Visit The START Hope Hub

    We believe that every patient should have the opportunity to access clinical trials, regardless of where they receive their cancer treatment. Designed to help you understand, explore, and enroll in early-phase oncology trials, the START Hope Hub will help guide you through the clinical trial process with confidence.

    Explore Hope Hub
    start_patients_and_family

    Patients & Family

    Patients

    Explore Clinical Trials

    About Clinical Trials

    Patient Stories

    Patient Advocacy Groups

    start_who_we_serve

    Referring Physicians

    Referring Physicians

    Hospitals & Oncology Practices

    Hospitals & Oncology Practices

    Pharma

    Pharma

  • START Locations

    START Research Centers

    100,000+ square feet of world-class research facilities

    United States Locations

    • USA START - San Antonio
    • USA START - Midwest
    • USA START - Mountain Region
    • USA START - Carolinas
    • USA START - Dallas Fort Worth
    • USA START - New Jersey
    • USA START - New York - Long Island
    • USA START - Los Angeles

    Europe Locations

    • Spain START - Madrid - CIOCC
    • Spain START - Madrid - FJD
    • Spain START - Barcelona
    • Spain START - Rioja
    • Spain START - Pediatrics
    • Portugal START - Lisbon
    • Ireland START - Dublin

  • Resources

    Resources

    Stay up to date with everything at START, from blog insights and press and newsroom updates to expert-led webinars and much more.

    Resources

    • Blog
    • Events
    • Newsroom
    • Press
    • Publications
    • Webinars

    Featured Resources

    Newsroom

    START and OneOncology Partner To Expand Access to Early Phase Oncology Trials

    Newsroom

    START Doses First U.S. Patient in Moderna’s Phase 1 Clinical Trial of mRNA-4106, a Pan-Tumor Antigen Therapy Candidate, in Solid Tumors

  • Hope Hub
  • Find a Trial
  • About

    About START

    Welcome to the START Center for Cancer Research. We are a global leader in cancer research, dedicated to the relentless pursuit of hope for patients and their families.

    About

    Company

    Hope Hub

    Leadership

    Principal Investigators

    Careers

    Contact

    Our Services

    Preclinical

    Early Phase

  • Who We Serve

    Visit The START Hope Hub

    We believe that every patient should have the opportunity to access clinical trials, regardless of where they receive their cancer treatment. Designed to help you understand, explore, and enroll in early-phase oncology trials, the START Hope Hub will help guide you through the clinical trial process with confidence.

    Explore Hope Hub

    Patients & Family

    Patients

    Explore Clinical Trials

    About Clinical Trials

    Patient Stories

    Referring Physicians

    Referring Physicians

    Hospitals & Oncology Practices

    Hospitals & Oncology Practices

    Pharma

    Pharma

  • START Locations

    START Research Centers

    100,000+ square feet of world-class research facilities

    United States Locations

    USA START - San Antonio

    USA START - Midwest

    USA START - Mountain Region

    USA START - Carolinas

    USA START - New York City (Coming Soon)

    Europe Locations

    Spain START - Madrid - CIOCC

    Spain START - Madrid - FJD

    Spain START - Barcelona

    Spain START - Rioja (Coming Soon)

    Portugal START - Lisbon

    Ireland START - Dublin

  • Resources

    Resources

    Stay up to date with everything in and around START.

    Resources

    Blog

    Events

    Newsroom

    Press

    Publications

    Webinars

    Featured Resources

    Newsroom

    START and OneOncology Partner To Expand Access to Early Phase Oncology Trials

    Newsroom

    START Doses First U.S. Patient in Moderna’s Phase 1 Clinical Trial of mRNA-4106, a Pan-Tumor Antigen Therapy Candidate, in Solid Tumors

  • About Clinical Trials
  • What to Expect
  • Patient Stories
  • FAQs
  • Healthcare Professionals
  • Hope Hub Contact Form
  • Hope Hub
  • Find a Trial
  • About Clinical Trials
  • What to Expect
  • Patient Stories
  • FAQs
  • Healthcare Professionals
  • Hope Hub Contact Form
Powered by:
© 2025 START. All rights reserved.